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Abstract
Influenza virus typically alters protein glycosylation in order to escape immune pressure from hosts and hence to facilitate
survival in different host environments. In this study, the patterns and conservation of glycosylation sites on HA and NA of
influenza A/H1N1 viruses isolated from various hosts at different time periods were systematically analyzed, by employing a
new strategy combining genome-based glycosylation site prediction and 3D modeling of glycoprotein structures, for
elucidation of the modes and laws of glycosylation site alteration in the evolution of influenza A/H1N1 viruses. The results
showed that influenza H1N1 viruses underwent different alterations of protein glycosylation in different hosts. Two
alternative modes of glycosylation site alteration were involved in the evolution of human influenza virus: One was an
increase in glycosylation site numbers, which mainly occurred with high frequency in the early stages of evolution. The
other was a change in the positional conversion of the glycosylation sites, which was the dominating mode with relatively
low frequency in the later evolutionary stages. The mechanisms and possibly biological functions of glycosylation site
alteration for the evolution of influenza A/H1N1 viruses were also discussed. Importantly, the significant role of positional
alteration of glycosylation sites in the host adaptation of influenza virus was elucidated. Although the results still need to be
supported by experimental data, the information here may provide some constructive suggestions for research into the
glycosylation of influenza viruses as well as even the design of surveillance and the production of viral vaccines.
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Introduction
Influenza virus can cause occasional pandemics and seasonal
epidemics in humans [1]. The great threat and high frequency of
variation of influenza viruses make the study of their evolutionary
mechanisms for host adaptation an urgent necessity in order to
predict and prevent the outbreak of potential new influenza
pandemics in the near future [2]. The H1N1 virus was an ideal
model for this purpose due to its long history of association with
humans, as well as co-circulation with the H3N2 virus in swine
and avian hosts [3,4,5].
The genome of the influenza A virus encodes 11 proteins.
However, only hemagglutinin (HA) and neuramidinase (NA)
undergo N-linked glycosylation, and no observation of O-linked
glycosylation has been reported [6,7]. HA and NA are critical
determinants of the host specificity, virulence and infectivity of the
influenza A virus. Glycosylation of HA and NA can affect the host
specificity, virulence and infectivity of an influenza strain either
directly, by changing the biological properties of HA and NA [8],
or indirectly, by attenuating receptor binding [9,10,11,12,13],
masking antigenic regions of the protein [8,14,15,16,17], impeding
the activation of the protein precursor HA0 via its cleavage into
the disulfide-linked subunits HA1 and HA2 [18,19,20], regulating
catalytic activity or preventing proteolytic cleavage of the stalk of
NA [2,21,22]. N-linked glycosylation sites generally fall into the
N-X-S/T sequence motif (sequon) in which X denotes any amino
acid except proline [23]. The number and distribution of the
N-glycosylation sites over the viral proteome can therefore be
computationally determined by scanning the sequences for these
sequons [24,25].
Previous reports have shown that the seasonal H1N1 viruses
possess more N-glycosylation sequons in their HA sequences than
the 1918 H1N1 strain (A/South Carolina/1/18) [17,25,26,27].
Two highly conserved glycosylation sites (Asn 142 and Asn 177) in
the receptor binding domain A (RBD-A) of HA in the seasonal
strains (represented by A/New Caledonia/20/1999) endow the
seasonal virus with resistance to antibodies directed against both of
the pandemic strains from 1918 and 2009 [26,28]. Because these
two glycosylation sites are absent in both pandemic strains, cross-
neutralization can occur between the two temporally distant pan-
demic influenza viruses, although both are insensitive to antisera to
1999 NC. In addition, the focus of the immune response to HA in
both seasonal and pandemic strains could be selectively changed
by the removal or addition of glycans on glycosylation sites 142
and 177 [26,28]. Das and coworkers [17] also reported the in-
fluence of N-glycosylation on HA evolution by employing bioin-
formatics tools. In addition, Wu and coworkers [22] showed that
the distinct N-glycan profiles of NA from the 1918 pandemic
influenza virus might cause viral resistance to proteinase digestion
as well as high infectivity. Protein glycosylation is beginning to be
PLoS ONE | www.plosone.org 1 July 2011 | Volume 6 | Issue 7 | e22844recognized as one of the important ways influenza viruses evolve
[26,29]. However, the alteration modes and laws of protein
glycosylation in the evolution of influenza A/H1N1 viruses are not
fully understood.
In this study, the patterns and conservation of the potential N-
glycosylation sites in 2,773 full-length amino acid sequences of HA
and 3,249 full-length amino acid sequences of NA for influenza
H1N1 viruses were systematically analyzed by employing a series
of bioinformatics tools. The alteration modes and laws of protein
glycosylation sites in terms of the evolution of human influenza
H1N1 viruses were discussed. And the significant role of positional
alteration of glycosylation sites in the host adaptation of influenza
virus was elucidated.
Materials and Methods
Protein sequence data of HA and NA from influenza
A/H1N1 viruses
A total of 2,773 full-length amino acid sequences of HA and
3,249 full-length amino acid sequences of NA from influenza A
(H1N1) viruses isolated from various hosts were downloaded from
the influenza virus resource at the National Center for Bio-
technology Information (NCBI) (http://www.ncbi.nlm.nih.gov/
genomes/FLU/FLU.html) [30,31] as of March 30, 2010. For
evolutionary analysis, the human seasonal influenza H1N1
viruses were further divided into several groups according to
their glycosylation site patterns. Before predicting the potential N-
glycosylation sites of HA and NA, multiple-alignments of the HA
and NA sequences were performed using the influenza virus
sequence alignment tool available at the NCBI website (http://
www.ncbi.nlm.nih.gov/genomes/FLU/Database/nph-select.cgi?go
=alignment) [30]. Note that when the number of sequences used
exceeds the maximum of 1000 that is allowed to run on the NCBI
sequence alignment server, the sequences were separated into two
or three groups. After alignments, they were merged into one file
again for further analysis. Swine strains isolated from humans were
not included in the human seasonal influenza viruses.
Prediction and statistical analysis of potential
N-glycosylation sites
Sequon Finder was used to predict N-glycosylation sites on HA
and NA and to perform statistical analysis of the glycosylation site
conservation among the viruses. Sequon Finder is a custom-made
program that just simply finds all sequons (N-X-S/T, where X is
not P) within protein sequences and supposes all of sequons as
potential glycosylation sites. Then it will compute the percentages
of the sequon appeared at each location in all protein sequences as
the conservation of the potential glycosylation site among homo-
logous proteins. The number of glycosylation sites was obtained
from a single monomer of HA and NA and the locations of the
glycosylation sites on HA and NA were numbered according to the
full- length HA sequence of South Carolina/1/1918 and the full-
length NA sequence of Brevig Mission/1/1918, respectively. The
results of the statistical analysis were manually validated. The
program is available upon request.
Homology modeling, in silico protein glycosylation and
visualization
To visualize and determine the positions of the glycosylation
sites, the 3D structures of representative HA and NA proteins with
different patterns of potential N-glycosylation sites in human in-
fluenza A (H1N1) viruses were generated using SWISS-MODEL
(http://swissmodel.expasy.org/) [32]. The crystal structure of A/
puerto rico/8/1934 HA (PDB code: 1RU7, http://www.rcsb.org)
and A/California/04/2009 HA (PDB code: 3LZG) were used as
the HA models of the human influenza H1N1 viruses before and
after 2000, respectively. An influenza A (H5N1) NA (PDB code:
2hty) was used as the NA model. After homology modeling,
glycans were added onto the potential N-glycosylation sites of HA
and NA using the Glyprot Server (http://www.glycosciences.de/
modeling/glyprot/) [33]. Complex glycan structures were selected
for all accessible sites, and the terminal sialic acid residues were
manually removed. All of the figures were generated and rendered
using MacPyMOL [34].
Results
Comparison of glycosylation site patterns on HA and NA
between human pandemic and seasonal influenza
viruses
First, we compared the patterns of potential N-glycosylation sites
for the HA and NA sequences of 1918 and 2009 pandemic human
influenza A (H1N1) viruses as well as human seasonal influenza
H1N1 viruses. Pandemic viruses are newly emerging viruses, and
thus may be the origin of seasonal viruses. While human seasonal
viruses originating from pandemic viruses may have undergone
many changes in its antigenic structure (called antigenic drift)
[1,5]. Therefore, the comparison of seasonal to the 1918 and 2009
pandemics can speculate the overall trends of glycosylation site
alteration in seasonal viruses.
The results showed, as had been reported previously [17,25,
26,27], that the seasonal viruses had more glycosylation sites on
the head of HA and NA than the 1918 and 2009 pandemic
viruses, and that two glycosylation sites (glycosylation sites 50 and
68) on the stalk of the NA in pandemic viruses likely be replaced
by another two glycosylation sites (glycosylation site 44 and 70) in
seasonal strains (Table 1, Table 2). Besides, there was also one
more glycosylation site on both HA (glycosylation site 293) and
NA (glycosylation site 386) of the pandemic 2009 strains than that
of the pandemic 1918 strains. Note that one HA sequence and one
NA sequence should still be able to represent glycosylation site
patterns of HA and NA in pandemic 1918 virus, as pandemic
1918 viruses had originated from avian influenza viruses [5] and
almost all avian influenza viruses possessed the same glycosylation
site patterns on HA and NA as that of the pandemic 1918 virus
(Table 1).
Alteration of glycosylation site numbers on HA and NA in
the evolution of human seasonal influenza viruses
To trace the history of the acquisition of new glycosylation sites
on both HA and NA of the human seasonal H1N1 viruses, we
systematically investigated the glycosylation site patterns in the HA
and NA of human strains over the last 92 years (from 1918 to
2009). According to the glycosylation site patterns that would
result from the acquisition, loss or positional conversion of poten-
tial glycosylation sites, the evolution of both HA and NA gly-
cosylation for human seasonal H1N1 virus can be separated into
several phases (Table S1, Table S2). Note that a new set of human
seasonal strains would be grouped when a new glycosylation site
appeared or an existed glycosylation site disappeared (conversion
of the glycosylation site ,5%). And the seasonal strains isolated in
1933 (including the WSN strains) were not included in the further
analysis, as they might be selected for changes following extensive
in vitro and in vivo passage in the laboratory for mouse
neurovirulence [35,36].
For HA (Table 1), five potential glycosylation sites at positions
27, 28, 40, 304 and 498 on the stalk were strictly conserved in all
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conserved, but it might not be glycosylated as this site was located
at the intracellular region of HA. Pandemic 1918 A/H1N1 viruses
had only one potential oligosaccharide at location 104 of the
globular head of HA. However, the 1934–1936 isolates (repre-
sented by A/Phila/1935) lost glycosylation site 104 and acquired
two new glycosylation sites at locations 286 and, occasionally, 144.
The 1940–1949 isolates (represented by A/AA/Huston/1945)
reacquired glycosylation site 104 and acquired an additional
glycosylation site at location 179. From 1950 to 1957, the isolates
(represented by A/Albany/1618/1951) lost glycosylation site 179
and gained three more glycosylation sites at locations 90, 172 and
177. When seasonal H1N1 viruses reappeared in 1977, the isolates
lost glycosylation site 90. In 1986, glycosylation site 142 replaced
glycosylation site 144 and a new glycosylation site at location 71
appeared. Then, glycosylation site 172 was lost in 1988, and
glycosylation site 286 disappeared in 1998. Therefore, the seasonal
A/H1N1 strains recently circulating in humans have two more
glycosylation sites (sites 142 and 177) on the top of the HA head
and one more (site 71) on the side of the HA head than the
pandemic 1918 strains.
For NA (Table 2), there were seven potential glycosylation sites
(four on the stalk and three on the head) on the NA of the
pandemic 1918 isolates. The 1934 isolates, just like the 1933
strains (Table S2), were a little abnormal which may resulted from
their propagation in eggs prior to sequencing [35,36]. The 1935
isolates added one glycosylation site at location 44 and the 1936–
1947 isolates added one glycosylation site at location 365. In 1948,
the viruses lost glycosylation site 50 and gained a new glycosylation
site at location 455. Glycosylation site 68 was replaced by
glycosylation site 70 in 1980. An addition glycosylation site at
residue 434 appeared in 1986 and glycosylation site 365 was lost
in 1988. From then on, the human seasonal A/H1N1 strains
appeared two new glycosylation sites on the head of the NA
compared with the pandemic 1918 strains, besides one new
glycosylation site at residue 386, which appeared in more than half
of the strains isolated in 2000 (Table S2).
Based on the analysis above, the overall trends of glycosylation
site alteration in the evolution of human seasonal A/H1N1 viruses
were that the glycosylation site numbers increased continuously
before 1950 for both HA and NA, then the numbers almost
stayed constant, but positional conversion became the dominating
mode.
Alteration of glycosylation site locations on HA and NA in
the evolution of human influenza viruses
To further analyze the positional conversion of glycosylation
sites on HA and NA in human H1N1 viruses, we modeled the HA
and NA proteins from some representative human strains using
known structures of homologous proteins as a model and then
added complex glycans to all accessible glycosylation sites on the
modeled proteins. The results showed that although most of the
potential glycosylation sites on HA (Figure 1a) and NA (Figure 1b)
were occupied by glycans, the glycosylation of potential glycosyl-
ation sites 27, 144 and 104 on HA was obstructed by the steric
hindrance of surrounding amino acid residues and the glycans
attached at glycosylation sites 28, 172 (represented by A/Albany/
1618/1951) and 71 (represented by A/NY/638/1995), respec-
tively. In addition, the fact that potential glycosylation site 27 on
HA couldn’t be glycosylated had been confirmed in H5N1
influenza virus by mass spectrometric analysis previously [7]. The
3D structures of glycosylated HA and NA revealed that the
glycosylation site alteration, especially positional conversion,
mainly located at two important regions of the HA head, termed
region A and region B (Figure 1c), and one region of the NA head,
termed region C (Figure 1d). The possibly positional conversion of
glycosylation sites in regions A and B of HA as well as region C
and stalk region of NA was shown in Figure 2.
Region A locates at the top of the HA head, including gly-
cosylation sites 142, 144, 172, 177 and 179 (Figure 2a). It has been
confirmed that the glycans at glycosylation sites 142 and 177 could
effectively block an immune reaction from antibodies directed
against both pandemic 1918 and 2009 strains [26], we speculated
that the glycans at glycosylation sites 144, 172 and 179 might have
the same function. The glycans at glycosylation sites 142 and 177
may shield the antigenic site Sa more effectively because they are
located at the center Sa, while glycosylation sites 172 and 179 are
at the edge of the antigenic site and glycosylation site 144 is just
adjacent to Sa (Figure 1c).
Region B, which belongs to the vestigial esterase domain and
may have played a role as a fusion protein that inserted the virus
into an ancestral membrane before giving rise to the modern
version of HA [37], includes glycosylation sites 71, 104 and 286
(Figure 2b). One of the functions of the glycan at glycosylation site
104 is likely to shield the antigenic site Ca2, but the glycosyla-
tion of this site might be obstructed by the steric hindrance
of surrounding amino acid residues. This obstruction could be
weakened greatly when glycosylation occurred at glycosylation site
71(Figure 1c). In addition, the glycan at glycosylation site 71 could
also shield Ca2 as well as glycosylation sites 104 and 286. Thus, it
is not surprising that glycosylation site 71 replaced the glycosyl-
ation sites 104 and 286 eventually.
There are three glycosylation sites (glycosylation sites 146, 365
and 434) around the enzymatic active site of each NA monomer
(Region C in Figure 1d and Figure 2c). Glycosylation at glycosy-
lation site 146 of NA might be necessary for the function of NA
and even for the survival of the virus because glycosylation site 146
was highly conserved in almost all H1N1 strains regardless of the
host (Table 2). Glycosylation sites 365 and 434 belonged to
antigenic sites 5 and 7, respectively (Figure 1d). Therefore, the
glycans attached to both sites could increase the resistance of the
virus to host immunity and/or regulate the activity of NA. Besides,
glycosylation site 434, like glycosylation site 146, is at the subunit
interface. So the glycan at glycosylation site 434 may also have a
function of stabilizing the NA tetramer, which should be one of the
important reasons that glycosylation site 434 replaced glycosyla-
tion site 365 entirely in 1988.
Positional conversions of glycosylation sites also occurred in
the NA stalk region of the human seasonal influenza viruses
(Figure 2d). The stalk region of NA is probably the most exposed
and vulnerable region to protease attacks, as NA is frequently
released from viral particles through proteolytic cleavage of this
region [22,38,39,40]. The glycans at glycosylation sites 44 and 70
may be more effectively than at glycosylation sites 50 and 68 in
protecting the NA stalk avoiding the effects from human proteases.
It can be concluded from the analysis above that glycosylation
site alteration occurred more frequently on HA than on NA, and
more frequently on the top of the HA head than on the side of the
HA head. Positional conversion of glycosylation sites, especially
the positional conversion occurred at many new glycosylation sites
acquired in the early stages of the evolution of influenza virus (such
as glycosylation site 365 on NA convert to site 434, and
glycosylation sites 144 and 179 on HA convert to sites 142 and
177, respectively), implied the significance of location of glycans on
both HA and NA for maximization of their biological functions in
the evolution of human influenza A/H1N1 viruses.
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Generally, the speed with which a new mutant strain overtakes
the original strain indicates the new strain’s superiority. For the
glycosylation site alteration on HA and NA of influenza A/H1N1
virus, though this analysis is hindered by the limited number of
sequences available until 1995, the overall tendency was that a
new mutant strain with positional conversion of glycosylation sites
on HA and NA could more rapidly overtakes the original strain
than a new mutant strain with simple acquisition of new gly-
cosylation sites on HA and HA (Table 1 and 2). For example, the
conservation levels of glycosylation sites 144 and 172 on HA and
glycosylation site 365 on NA were low when they first appeared,
and then it gradually increased. While glycosylation sites 142 and
71 on HA and glycosylation sites 434 on NA were highly
conserved since they first appeared, This implied that positional
conversion of glycosylation sites might be a more effective mode of
glycosylation site alteration for the evolution of influenza A/H1N1
viruses. The relatively low frequency of positional conversion of
glycosylation sites in the later stages of evolution also supported
this conclusion.
Glycosylation site alteration on HA and NA of influenza
viruses from other hosts
In recent decades, both classical swine influenza and triple-
reassortant swine influenza viruses have occasionally been isolated
from humans [41,42], such as during the 1976 outbreak in Fort
Dix, New Jersey [41,43]. Our analysis showed that these swine
influenza strains isolated from humans had identical patterns for
potential glycosylation sites on HA and NA as the pandemic 1918
and 2009 strains, but completely different patterns from the
human seasonal strains circulating during the same periods (Figure
S1 and S2, Tables S1 and S2).
For further analysis of the glycosylation site alteration in
influenza A/H1N1 viruses from other hosts, we further analyzed
the patterns of the potential glycosylation sites on HA and NA of
influenza A/H1N1 viruses isolated from avian and swine (Table 1,
Table 2). The different glycosylation site patterns on HA and NA
Figure 1. Structural overviews of the HA and NA monomers for human influenza H1N1 viruses. Each represented a unique glycosylation
site pattern on HA or NA. (A) The monomers of HA with glycans attached at the potential glycosylation sites for representative human influenza H1N1
viruses from 1918 to 2010. (B) The monomers of NA with glycans attached at the potential glycosylation sites for representative human influenza
H1N1 viruses from 1918 to 2010. (C) A monomer of HA with the location of the receptor-binding site (RBS) and the five antigenic sites [48,49]. Regions
A and B are important regions with frequently altered glycosylation sites. (D) A monomer of NA with the location of the enzyme active site and the
seven antigenic sites surrounding the enzyme active [40,50]. Region C is an important glycosylation region surrounding the enzyme active site. The
amino acid locations are numbered according to the HA of SC 1918 and NA of BM 1918 numbering, respectively.
doi:10.1371/journal.pone.0022844.g001
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implied the different evolutionary processes of influenza H1N1
viruses in different hosts, and the different evolutionary paths of
H1N1 viruses implied different immune systems and selective
pressures against influenza viruses in different hosts. Based on the
analysis above, it could be concluded that avian possessed the
lowest selective pressure, while human possessed the highest
selective pressure against influenza A/H1N1 virus. All influenza
A/H1N1 viruses isolated from other mammals (including cat,
ferret and giant anteater) possessed the same glycosylation site
patterns as the human seasonal and pandemic influenza viruses
and depended on the predominant strains circulating in humans at
the time. But these data were not included in the study on account
of insufficiency of HA and NA sequences available for statistical
analysis (Table S1 and S2).
Discussion
Genome-based approaches were typically used when investi-
gating changes in glycosylation, as well as when predicting func-
tion, due to the great simplicity of these measurements [6,25,
27,44]. Such studies were based upon locating the sequon in the
amino acid sequence predicted by the viral RNA. This method
was based on the assumption that all potential N-glycosylation
sites were occupied. Unfortunately, the amino acid sequence is
only one determinant of glycosylation because the location of
glycosylation sites and the host environment also have a strong
effect on glycosylation [8,29,45,46]. Moreover, the amino acid
sequence of glycoproteins alone is not sufficient to obtain the
location information of glycosylation sites in the 3D structures of
glycoproteins. In this study, a series of bioinformatics tools were
used to maximize the reliability of this strategy. First, all of the
sequons were found from 2,773 full-length amino acid sequences
of HA and 3,249 full-length amino acid sequences of NA from
influenza H1N1 viruses over a 93-year period and were assumed
to be potential glycosylation sites. Then, the structures of repre-
sentative HA and NA proteins from human influenza A (H1N1)
viruses were modeled, including their different patterns of poten-
tial N-glycosylation sites. Finally, glycans were added in silico onto
each glycosylation site using the Glyprot server to confirm that
these potential glycosylation sites could be glycosylated, and the
structures of the obtained glycoproteins were further used to
determine the location of glycosylation sites.
Our results showed that two modes of protein glycosylation site
alteration were involved in the evolution of human seasonal
influenza viruses. The first mode was to increase the number of
glycosylation sites. This mode was obvious and have been reported
many times before in both human H1N1 and H3N2 viruses
[6,17,25,26,27,44]. The other mode was the positional conversion
of glycosylation sites (also called glycosylation site substitution),
which occurs when the acquisition of a new glycosylation site in
the new strain is accompanied by the loss of an existing
Figure 2. The alteration processes of glycosylation sites in some important regions of HA and NA. (A) The alteration process of
glycosylation sites in region A (located at the receptor binding domain) of HA. (B) The alteration process of glycosylation sites in region B (located at
the vestigial esterase domain) of HA. (C) The alteration process of glycosylation sites in region C (located around the enzymatic active site) of NA. (D)
The alteration process of glycosylation sites on the stalk of NA. The dotted lines represented the superficial alterations based on genome-based
analysis, while the corresponding full lines illustrated the possibly alteration processes after further analysis by homology modeling and in silico
protein glycosylation.
doi:10.1371/journal.pone.0022844.g002
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may not occur simultaneously and the acquired glycosylation sites
may also not adjacent to the lost glycosylation sites in the primary
structures of the proteins, as some of the exchanges occurred over
an intermediate time and/or distance frame (for instance, the
conversion of glycosylation site 286 on HA to glycosylation site
71). This hides the second mode and makes it more likely to be
neglected in the evolutionary analysis of influenza viral protein
glycosylation [25]. Our results showed that the alteration of
glycosylation sites by the first mode mainly occurred with high
frequency in the early stages of viral evolution (1918–1949 for both
HA and NA of human influenza H1N1 viruses), while the second
mode mainly occurred with relatively low frequency in the later
stages (1950–2009 for both HA and NA of human influenza H1N1
viruses).
Our results also indicated that positional conversion of gly-
cosylation sites might be a more effectively alteration mode. The
presence of glycans on the head of HA and NA can have either
positive or detrimental effects on the virus [8,14]. While it shields
antigenic sites from immune recognition, it reduces receptor
affinity of HA and enzymatic activity of NA [8,14]. So the possible
process and mechanism of glycosylation site alteration in human
seasonal H1N1 virus are described below. Since only few glycans
attached at the antigenic sites and surrounding regions of HA and
NA in pandemic H1N1 viruses, the acquisition of new glycosy-
lation sites (increase in glycosylation site numbers) in these regions
mainly play its positive role in escaping antibody recognition from
hosts in the early evolution stages of seasonal strains, and thus it is
necessary for seasonal virus to continue to prevail among humans.
Then new immune antibodies to these seasonal strains are
gradually induced in the host, decreasing the transmissibility of
the virus. But if continuously added new glycans onto the anti-
genic sites, it would greatly reduces receptor affinity of HA and
enzymatic activity of NA. Therefore, alteration of glycan loca-
tion (positional conversion of glycosylation sites) became a more
suitable way for evolution of H1H1 viruses. By simply changing
the location of the glycans, but no new glycans added, the viruses
obtained the ability of escaping immune recognition from host
antibodies again. So the positional conversion of glycosylation sites
may be more artful than the increase of glycosylation site numbers
for the host adaptation of influenza virus.
In fact, we speculated that there might be a third alteration
mode of protein glycosylation that involved in the evolution of
influenza viruses: the alteration of glycan structures. This altera-
tion could be achieved either by direct changes to the mono-
saccharide components and bonds of the glycans at specific
glycosylation sites, or it could occur along with the positional con-
version of the glycosylation sites. When a glycan transferred form
one place to another, the glycan might also change to a new
structure. The new structure of the glycan rather than the
positional conservation of the glycosylation site might be the actual
factor that made the influenza virus obtained the ability to
continue to prevail among humans. However, it is still impossible
to predict the structure of all of the glycans on the different
glycosylation sites nowadays due to the complexity of glycans and
the lack of correspondingly competent analytical techniques and
tools. Therefore, this potential alteration mode was not included in
this study.
Among the methods used to control the rapid spread of influenza
viruses, vaccination remains the most effective [47]. A good vaccine
should induce immune responses that cross-neutralize either all
viruses in a subtype or, ideally, all influenza viruses. However,
altered protein glycosylation, just like varied amino acid sequences,
could affect the ability of antibodies to neutralize influenza viruses
and thus affect the effectiveness of the vaccines [26,29]. Therefore,
the glycosylation alteration of HA and NA may need to be taken
into consideration in global surveillance, vaccine production and
drug design for influenza viruses.
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Figure S1 Phylogenetic tree for HA amino acid sequenc-
es of selected influenza A/H1N1 viruses. The selected
viruses include swine strains isolated from humans, representative
strains isolated from swine as well as representative strains of
human seasonal viruses since 1976 and the pandemic 2009 strain.
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Figure S2 Phylogenetic tree for NA amino acid sequenc-
es of selected influenza A/H1N1 viruses. The selected
viruses include swine strains isolated from humans, representative
strains isolated from swine as well as representative strains of
human seasonal viruses since 1976 and the pandemic 2009 strain.
(TIF)
Table S1 The potential glycosylation sites of HA in
H1N1 influenza viruses from different hosts. The
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Table S2 The potential glycosylation sites of NA in
H1N1 influenza viruses from different hosts. The
sequence in each unit of table represents the corresponding sequon
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filling the units in yellow.
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